Aladdin Healthcare Technologies SE

Aladdin Healthcare Technologies SE: Antrag auf Eröffnung eines Insolvenzverfahrens

Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amount of approximately EUR 155,000

DGAP-DD: Aladdin Healthcare Technologies SE english

Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA

DGAP-DD: Aladdin Healthcare Technologies SE english

Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis

Aladdin Healthcare Technologies SE reports the sale of software and intellectual property

Aladdin Healthcare Technologies starts OTC Entry Level Listing in the USA and looks forward to further expansion

DGAP-DD: Aladdin Healthcare Technologies SE english

Aladdin Healthcare Technologies jointly develops AI-Platform for Cardiovascular Diseases that achieves three Patents in China

Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof

Aladdin Healthcare Technologies SE reports preliminary figures for financial year 2019 and readjustment of the 2018 financial year figures

Aladdin Healthcare Technologies discovers anti-osteoporosis nanomolar activity leads from natural compounds dataset with its Deep Learning Algorithms for drug discovery, validated by leading scientific publication ‘European Journal of Medicinal Chemistry’

DGAP-DD: Aladdin Healthcare Technologies SE english

DGAP-DD: Aladdin Healthcare Technologies SE english

DGAP-DD: Aladdin Healthcare Technologies SE english

Aladdin Healthcare Technologies completes AI-driven Drug Discovery Platform (AIDD) for Commercial Use in Drug Development

Aladdin Healthcare Technologies will obtain an equity stake in public spinoff No-Age Biotech Inc. at TSX, aimed to combat age-related diseases